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Group 2 includes individuals who were likely to have been
exposed to M. tuberculosis infections (HRG).
Results: Overall agreement between IFN-gamma assay
and TST was 89.3% (kappa = 0.052). In LRG, agreement
between the two tests was 52.6% (95% conﬁdence interval,
44—60%) with  values of 0.019. In HRG agreement between
the two tests was 63.2% (95% conﬁdence interval, 42—84%)
with  values of 0.28.
Conclusion: In conclusion, the IFN-gamma assay showed
acceptable results for determining latent M. tuberculo-
sis infection in vaccinated population. Although TST and
IFN-gamma assay appear comparable, they have differ-
ent performance and operational characteristics; therefore,
the decision to select one test over the other will
depend on the population, purpose of testing, and resource
availability.
doi:10.1016/j.ijid.2008.05.848
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Background: A Fluoroquinolone (FQN) is the drug of ﬁrst
choice for the treatment of multi-drug resistant tuber-
culosis (MDR TB) but the FQN-resistance rate in Vietnam
is unknown. A rapid and effective test to detect FQN-
resistance before treatment is urgently needed. FQNs inhibit
the function of the DNA gyrase, encoded by the gyrAB
genes of Mycobacterium tuberculosis and mutations in the
Quinolone Resistance Determining Region (QRDR) of gyrA
have been shown to account for 60—70% of FQN-resistant
isolates. A Real-time-PCR (RT-PCR) test was developed to
detect the most common mutations in this region.
Methods: gyrA sequencing data from 40 FQN-sensitive
and 42 FQN-resistant (oﬂoxacin 2g/ml) clinical isolates
was used to develop the RT-PCR test. Three Locked-Nucleic-
Acid probes were used to detect mutations at codons 90,
91 or 94 which accounted for 97% of the FQN-related muta-
tions in QRDR of gyrA. A set of 131 consecutive isolates from
retreatment patients from Pham Ngoc Thach Hospital, resis-
tant to either Isoniazid or Rifampin, was used to evaluate the
RT-PCR and estimate the resistance rate.
Results: Sequencing data showed that all 40 FQN-
sensitive isolates were wild-type in the QRDR. Among 42
FQN-resistant isolates, 10 were wild-type, 20 carried single
mutations and, surprisingly, 12 were heterogeneous contain-
ing both wild-type and mutated populations. Of these 12,
4 contained a mutation at 2 resistance-associated alleles.
The RT-PCR test identiﬁed all wild-type and single muta-
tion isolates correctly and 12/16mutations in heterogeneous
isolates. Five percent of isolates (7/131) from retreatment
patients were identiﬁed as FQN-resistant by RT-PCR and con-
ﬁrmed by sequencing.
Conclusion: This RT PCR assay is a quick, relatively simple
and cheap test to screen for FQN-resistance with 100% speci-
ﬁcity. FQN resistance is estimated at > 5% in retreatment
patients in Southern Vietnam. Studies to determine other
FQN-resistance mechanisms are vital to improve molecular
diagnosis and treatment.
doi:10.1016/j.ijid.2008.05.849
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Background: The aim of the present study was to assess
progress made in the diagnosis of pulmonary tuberculo-
sis when evaluating B-cell responses to 16 Ag85A synthetic
peptides, the recombinant antigen 85 (rAg85) and the non-
recombinant PPD antigen.
Methods: The B-cell responses of tuberculosis patients
and healthy individuals were evaluated by an IgG-ELISA. A
total of 120 individuals were included in this study. Patient
groups were conformed of 20 Warao indigenous (WP) and 20
Creole non-indigenous (CP), whilst healthy control groups
were composed by 40 Warao indigenous (WC) and 40 Creole
non-indigenous (CC). Both control groups included 20 posi-
tive and 20 negative individuals for the tuberculin skin test
(TST). Association of positive tests for each antigen, deﬁned
with receiver operator characteristics (ROC) analysis, was
assessed for each population.
Results: Different patterns of the B-cell responses
were displayed by each population. The anti-29878 IgG
method reached highest sensitivity of 95.0% (negative pre-
dictive value (NPV) = 94.4) within the Warao population,
but was lowly speciﬁc, 42.5%, (positive predictive value
(PPV) = 45.2), compared to highest speciﬁcity showed by
the anti-29879 IgG method (100.0%, PPV = 100). Regarding
the Creole population, anti-11006 IgG showed highest sen-
sitivity of 95.0% (NPV = 90) but was lowly speciﬁc (22.5%,
PPV = 38). Anti-10998 IgG was found to be the most spe-
ciﬁc (100.0%, PPV = 100), followed by the anti-PPD IgG
method (90.0%, PPV = 66.7). These ﬁndings indicate that
population-to-population heterogeneity of peptide antigen
recognition, rather than recognition of particular antigens,
is a characteristic feature of antibody responses in these two
populations. Furthermore, responses to anti-29879 IgG and
anti-10998 IgG were associated to inactive TB.
Conclusion: Ag85A peptides were more speciﬁc than sen-
sitive, showing that these peptides’ high speciﬁcity does not
stimulate primed T cells in TST+ individuals, suggesting that
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they might be useful in identifying population at a higher
risk of latent TB reactivation.
doi:10.1016/j.ijid.2008.05.850
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Background: Due to the emergence of multidrug resistant
TB (MDR-TB) in recent time, the rapid detection of resis-
tance to ﬁrst line antituberculosis drug such as Rifampicin
(which is generally considered a marker for determination
of MDR strains) was felt worldwide.
Methods: Rifampicin susceptibility of 22 rifampicin
resistant and 11 rifampicin susceptible Mycobacterium
tuberculosis strains was analyzed by PCR-Single Strand
Conformation Polymorphism(SSCP) and validated by DNA
sequencing within the 157 bp region of the rpo B gene(Ala500
to Val550) for checking its utility as a rapid screening test
for determination of MDR drug resistance.
Results: RMP resistance was detected successfully
by PCR-SSCP in 20/22(90.90%) of the RMP- resistant
strain. 2 RMPr strains showed identical PCR-SSCP pattern
with wild type H37Rv. There were seen seven differ-
ent mutation in the ampliﬁed region of rpo B gene
of 20 RMPr: codon 513(CAA→CCA), 516(GAC→GTC), 507
(GGC→GAC), 526(CAC→GAC, TAC), 531(TCG→TTG, TGG),
522(TCG→TGG), 533(GTG→CCG). Thus this study demon-
strated the high speciﬁcity(100%) and sensitivity(90.90%) of
PCR-SSCP method for detection of mutation in rpo B gene;
77.27% of RMPr strain showed a single mutation and 9.09%
had no mutation.
Conclusion: Our data support the common notion that
rifampicin resistance genotypes are generally present in
codons 516, 526, and 531, most frequently found in M. tuber-
culosis population regardless of geographic origin and can be
rapidly detected by PCR-SSCP making it as a useful tool in
primary screening of drug resistance.
doi:10.1016/j.ijid.2008.05.851
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Background: Resistance to rifampicin is considered as a
surrogate marker for MDR-TB. This putative rifampicin resis-
tance is associated with mutations that occur within a 69-bp
region of the rpoB gene, which encodes the  subunit of RNA
polymerase. This study was undertaken for the ﬁrst time
in Poland to detect and characterise the rpoB gene muta-
tion associated with rifampicin resistance in M. tuberculosis
isolates by INNO-LiPA Rif. Tb assay.
Methods: A total of 44 clinical samples collected from
patients with pulmonary and extra pulmonary tuberculosis
were used for study. The clinical samples were tested simul-
taneously by LiPA test and by conventional methods. Drug
susceptibility tests were performed by standard proportion
method. All of M. tuberculosis positive samples (in culture
or/and in LiPA test) were then evaluated by using LiPA kit for
any speciﬁc mutational pattern of rpoB gene. As a control,
H37Rv strain was used.
Results: Of the 44 clinical samples tested 23 of the spec-
imens were culture positive for M. tuberculosis. The LiPA
assay identiﬁed 44 of them as M. tuberculosis complex
and simultaneously detected the susceptibility pattern to
rifampicin. Among 44 strains, 32 rifampicin resistant strains
and 12 rifampicin sensitive strains were detected by using
LiPA kit. Of 32 resistant strains: 27 showed R types mutations
accounted for 61,3%, 4 strains demonstrated S type muta-
tions and only 1 strain revealed double mutations. Twelve
strains with no mutations were deﬁned as RMPs. The RPMr
strains revealed 7 different LiPA proﬁles. Of R type muta-
tions the R4b (H526D), R5 (S531L) and R2 (D516V) were
observed with followed frequencies -31,8%, 25,0% and 4,5%.
S type mutations occurred in 11,4% of analysed strains.
Conclusions: The results obtained by LiPA assay show that
the mutations of the rpoB gene at codons 516, 526 and 531
are predominant in M. tuberculosis Polish strains.
doi:10.1016/j.ijid.2008.05.852
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The recently dveloped phenol ammonium sulphate
(PHAS) sputum concentration method was compared to the
established sodium hypochlorite (NaOCl) method in diag-
nosis of pulmonary TB. Three hundred sputum specimens
were collected from patients with clinical symptoms of TB
in Harare, Zimbabwe. Specimens were emulsiﬁed using both
methods in parallel and concentrated by centrifugation. Pel-
lets were smeared on slides and stained by the ZN method
for AFB. A total of 80 (27%) were AFB positive by both
concentration methods. An additional 16(20%) were posi-
tive by the NaOCl method. The greater sensitivity of NaOCl
was statistically signiﬁcant (X2 = 70.605, d.f. = 1, p = 0.000).
More AFB were seen per high power ﬁeld using the NaOCl
method(ranked as 1+ or greater)than for PHAS. Also, the spu-
tum samples that had a low count of AFB (<1 per ﬁeld) using
NaOCl were negative using PHAS. The NaCOl concentration
method showed greater sensitivity in detecting pulmonary
TB than the PHAS method.
doi:10.1016/j.ijid.2008.05.853
